Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macro trends in pharmaceutical innovation.

Fredric J Cohen1

  • 1Crownstone, 3331 Street Road, Suite 140, Bensalem, Pennsylvania 19020, USA. fred@crownstonegroup.com

Nature Reviews. Drug Discovery
|February 3, 2005
PubMed
Summary

Major pharmaceutical companies face scrutiny over drug innovation. This analysis examines the reality of pharmaceutical innovation and the industry

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macro trends in pharmaceutical innovation.

Discovery medicine·2010
Same author

Entry order as a consideration for innovation strategies.

Nature reviews. Drug discovery·2006
Same author

Disappointing article, not disappointing biotech.

BMJ (Clinical research ed.)·2005
Same author

What ails the FDA?

The New England journal of medicine·2005
Same author

The fast track effect.

Nature reviews. Drug discovery·2004
Same author

RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.

Clinical cancer research : an official journal of the American Association for Cancer Research·2004

Area of Science:

  • Pharmaceutical industry analysis
  • Biotechnology innovation
  • Drug development trends

Background:

  • Public and critical perception of pharmaceutical innovation is often negative.
  • Questions arise regarding the extent and nature of innovation within major pharmaceutical companies.
  • The long-term viability of the pharmaceutical industry is linked to its innovative capacity.

Purpose of the Study:

  • To critically evaluate the current state of pharmaceutical innovation.
  • To determine if major pharmaceutical companies are still actively innovating.
  • To explore the mechanisms and strategies employed in pharmaceutical innovation.

Main Methods:

  • Review of critical perspectives on pharmaceutical R&D.
  • Analysis of industry trends and patent data.
  • Discussion of business models and survival strategies in the pharmaceutical sector.

Main Results:

  • The study addresses the debate on whether pharmaceutical companies truly innovate.
  • It explores the different ways in which innovation occurs within the industry.
  • The necessity of innovation for the survival of pharmaceutical companies is examined.

Conclusions:

  • The pharmaceutical industry's innovative capacity is a complex issue.
  • Understanding the drivers and challenges of pharmaceutical innovation is crucial.
  • The industry's future depends on its ability to adapt and innovate.

Related Experiment Videos